Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors.
Pivonello
R
R
Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Naples, Italy. rpivone@tin.it
Ferone
D
D
Filippella
M
M
Faggiano
A
A
De Martino
M C
MC
Auriemma
R S
RS
Rota
F
F
Lombardi
G
G
Colao
A
A
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D018358:Neuroendocrine Tumors / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D010911:Pituitary Neoplasms / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D013004:Somatostatin